SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-21-007392
Filing Date
2021-12-10
Accepted
2021-12-10 16:31:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9080302_13g.htm SC 13G 104329
  Complete submission text file 0000919574-21-007392.txt   105911
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90656 | Film No.: 211485787
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

IRS No.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G